Your top 3 questions about the union of Azara Healthcare and i2i answered
Jeff Brandes
President and CEO
Azara Healthcare
Justin Neece
CEO
i2i Population Health
Now more than ever, health systems and health plans require advanced technology to enhance population health management and better support underserved communities. Together, the union of i2i Population Health and Azara Healthcare — recognized with its third consecutive Best in KLAS win for population health management — will not only meet these critical needs, but drive meaningful innovation and impact.
The combined set of solutions will unify clinical, health plan, HIE, and SDOH data to deliver a complete picture of patient health and risk factors — enabling provider organizations to close critical care gaps, lower healthcare costs by optimizing utilization, and more.
Jeff Brandes, President and CEO of Azara Healthcare, and Justin Neece, CEO of i2i Population Health, share their insights on what to expect now that healthcare’s leading population health and value-based care technology innovators have joined forces.
Why are Azara Healthcare and i2i uniting?
Jeff Brandes: At its core, our merged company will deliver industry-leading population health and value-based care solutions to payers and providers who support underserved communities. We’re incredibly excited about this — both companies have been serving these markets for a long time. We all feel that we’re bringing together the best that both companies have been delivering to help support the mission of our clients.
Together, we will supercharge the safety net that delivers care to people who most need it. Azara and i2i have deep experience in supporting providers who care for underserved populations. By joining forces, our combined network of providers will enhance care and outcomes for over 50 million Americans, driving meaningful improvements in patient health and expanding our impact even further.
What are the joint capabilities between the solutions? What are the benefits for your clients and those they provide care for?
Jeff Brandes: This new collaboration addresses what we know are some of healthcare's most crucial challenges, such as our ability to help our clients lower healthcare costs by optimizing utilization of services. Our solutions also help alleviate some traditional friction by facilitating collaboration between providers and payers. Together, the two solutions also help streamline regulatory and compliance reporting.
Justin Neece: The combined set of solutions will unify clinical, health plan, HIE, and SDOH data to deliver a complete picture of patient health and risk factors. This allows provider organizations to close critical care gaps that improve quality performance and drive lower healthcare costs.
All of these factors together help Azara and i2i stand out in a crowded sea of solutions, at a time when providers and health plans are faced with more challenges than ever. Comprehensive capabilities to help solve them means healthcare teams can focus on providing superior care.
What does this union mean for the future?
Jeff Brandes: We are dedicated to our customers, who are thoroughly committed to providing the highest-quality patient care. With the support of an investment from Insight Partners, we’re excited to lead the joint Azara and i2i team as they drive transformative advancements in population health. Our combined solutions will empower over 1,000 providers and dozens of payers to achieve greater impact and improve health outcomes on a broader scale.
Justin Neece: There’s magnitude behind that number — but it’s always been important to both companies to keep in mind that no matter how big the number is, each patient, each provider, and each health plan matters on an individual level. Technology that supports those on the front lines and makes a difference in communities across the country, whether rural or urban, large or small, has always – and will continue to remain — our shared North Star.
For more details about the union of Azara Healthcare and i2i, watch the video featuring Jeff Brandes and Justin Neece.
